51 HIV patients and caregivers viewpoints towards participation to future HIV cure-related clinical trials – results from the second part of the French ANRS-APSEC survey

51 HIV patients and caregivers viewpoints towards participation to future HIV cure-related clinical trials – results from the second part of the French ANRS-APSEC survey

Bibliographic Details
Main Authors:	C. Protière, O. Lambotte, M. Mora, M. Doumergue, M. Préau, C. Goujard, P. Morlat, I. Poizot-Martin, F. Raffi, D. Zucman, L. Meyer, B. Spire, M. Suzan-Monti
Format:	Article
Language:	English
Published:	Elsevier 2016-07-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664020309961

Similar Items

Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC).
by: Christel Protière, et al.
Published: (2017-01-01)

Characterization of Physicians That Might Be Reluctant to Propose HIV Cure-Related Clinical Trials with Treatment Interruption to Their Patients? The ANRS-APSEC Study
by: Christel Protiere, et al.
Published: (2020-06-01)

What is the effect of self-identified HIV activism in willingness to participate in HIV cure-related clinical trials? Results from the ANRS-APSEC study
by: Marion Fiorentino, et al.
Published: (2019-07-01)

Immunologic and Virologic Progression in HIV Controllers: The Role of Viral "Blips" and Immune Activation in the ANRS CO21 CODEX Study.
by: Nicolas Noel, et al.
Published: (2015-01-01)

Correction: Expanding Access to Non-Medicalized Community-Based Rapid Testing to Men Who Have Sex with Men: An Urgent HIV Prevention Intervention (The ANRS-DRAG Study).
by: Nicolas Lorente, et al.
Published: (2013-01-01)

Suicide risk in a representative sample of people receiving HIV care: Time to target most-at-risk populations (ANRS VESPA2 French national survey).
by: Maria Patrizia Carrieri, et al.
Published: (2017-01-01)

Expanding access to non-medicalized community-based rapid testing to men who have sex with men: an urgent HIV prevention intervention (the ANRS-DRAG study).
by: Nicolas Lorente, et al.
Published: (2013-01-01)

Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study.
by: Sarah Shili-Masmoudi, et al.
Published: (2019-01-01)

Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study.
by: Cyril Dalmasso, et al.
Published: (2008-01-01)

Correction: Expanding Access to Non-Medicalized Community-Based Rapid Testing to Men Who Have Sex with Men: An Urgent HIV Prevention Intervention (The ANRS-DRAG Study)
by: Nicolas Lorente, et al.
Published: (2013-01-01)

CD4 dynamics over a 15 year-period among HIV controllers enrolled in the ANRS French observatory.
by: Faroudy Boufassa, et al.
Published: (2011-01-01)

The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): Early findings, 2006-2010
by: Rouges François, et al.
Published: (2010-10-01)

Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort.
by: Oumar Billa, et al.
Published: (2018-01-01)

Antiretroviral therapy for HIV controllers: Reasons for initiation and outcomes in the French ANRS-CO21 CODEX cohort
by: Léo Plaçais, et al.
Published: (2021-07-01)

Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH)
by: Saskia Antwerpes, et al.
Published: (2020-08-01)

Intimate partner violence against HIV-positive Cameroonian women: Prevalence, associated factors and relationship with antiretroviral therapy discontinuity—results from the ANRS-12288 EVOLCam survey
by: Marion Fiorentino, et al.
Published: (2019-06-01)

Intimate partner violence by men living with HIV in Cameroon: Prevalence, associated factors and implications for HIV transmission risk (ANRS-12288 EVOLCAM).
by: Marion Fiorentino, et al.
Published: (2021-01-01)

A generalized additive model to disentangle age and diagnosis-specific cohort effects in psychological and behavioral outcomes in people living with HIV: the French cross-sectional ANRS-VESPA2 survey
by: Luis Sagaon-Teyssier, et al.
Published: (2019-05-01)

Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)
by: Florian Liégeois, et al.
Published: (2020-01-01)

Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial.
by: Odile Launay, et al.
Published: (2007-08-01)

Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal
by: Orne-Gliemann, J., et al.
Published: (2015)

Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study.
by: Asier Sáez-Cirión, et al.
Published: (2013-03-01)

Preservation of IL-17 producing γδ T cells and their role in the control of immune activation in HIV controllers: ANRS EP56 study
by: L. Weiss, et al.
Published: (2017-12-01)

Immunodeficiency, HIV RNA plasma viral load and risk of AIDS-defining and non-AIDS-defining neoplasia, ANRS CO3 Aquitaine Cohort (1998–2006)
by: Lawson-Ayayi S, et al.
Published: (2009-06-01)

Feasibility of early infant diagnosis of HIV in resource-limited settings: the ANRS 12140-PEDIACAM study in Cameroon.
by: Mathurin C Tejiokem, et al.
Published: (2011-01-01)

Susceptibility to transmitting HIV in patients initiating antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER Trial).
by: Gilbert Ndziessi, et al.
Published: (2013-01-01)

Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts.
by: Evguenia Krastinova, et al.
Published: (2013-01-01)

Can HIV incidence testing be used for evaluating HIV intervention programs? A reanalysis of the Orange Farm male circumcision trial (ANRS-1265)
by: Laeyendecker Oliver, et al.
Published: (2010-05-01)

Correction: Susceptibility to Transmitting HIV in Patients Initiating Antiretroviral Therapy in Rural District Hospitals in Cameroon (Stratall ANRS 12110/ESTHER Trial)
by: Gilbert Ndziessi, et al.
Published: (2013-01-01)

Correction: Susceptibility to Transmitting HIV in Patients Initiating Antiretroviral Therapy in Rural District Hospitals in Cameroon (Stratall ANRS 12110/ESTHER Trial).
by: Gilbert Ndziessi, et al.
Published: (2013-01-01)

P16-45. High avidity CD4+ T cell response directed to an immunodominant Gag epitope in HIV controllers: an ANRS EP36 study
by: Thèze J, et al.
Published: (2009-10-01)

Primary HIV infection: the French experience
by: Goujard Cécile
Published: (2012-05-01)

Adherence to quarterly HIV prevention services and its impact on HIV incidence in men who have sex with men in West Africa (CohMSM ANRS 12324 – Expertise France)
by: Ter Tiero Elias Dah, et al.
Published: (2021-05-01)

Loss of long-term non-progressor and HIV controller status over time in the French Hospital Database on HIV - ANRS CO4.
by: Sophie Grabar, et al.
Published: (2017-01-01)

New and old complex recombinant HIV-1 strains among patients with primary infection in 1996–2006 in France: The French ANRS CO06 primo cohort study
by: Peeters Martine, et al.
Published: (2008-08-01)

HIV controllers: state of the art
by: Lambotte Olivier
Published: (2010-05-01)

Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.
by: Bertran Auvert, et al.
Published: (2005-11-01)

Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.
Published: (2005-11-01)

Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study.
by: Camille Legeai, et al.
Published: (2013-01-01)

Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study
by: Olivier Ségéral, et al.
Published: (2018-03-01)